News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ZymoGenetics, Inc. (ZGEN) Kidney Disease Drug Study Stopped


10/28/2008 7:24:42 AM

Shares in ZymoGenetics Inc. fell more than 28 percent in Monday trading after the Seattle biotech announced that a test of one of its drugs targeted at kidney disease has been discontinued.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES